537 related articles for article (PubMed ID: 27178731)
1. G protein-coupled receptor kinases as regulators of dopamine receptor functions.
Gurevich EV; Gainetdinov RR; Gurevich VV
Pharmacol Res; 2016 Sep; 111():1-16. PubMed ID: 27178731
[TBL] [Abstract][Full Text] [Related]
2. Altered expression and subcellular distribution of GRK subtypes in the dopamine-depleted rat basal ganglia is not normalized by l-DOPA treatment.
Ahmed MR; Bychkov E; Gurevich VV; Benovic JL; Gurevich EV
J Neurochem; 2008 Mar; 104(6):1622-36. PubMed ID: 17996024
[TBL] [Abstract][Full Text] [Related]
3. L-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brain.
Bezard E; Gross CE; Qin L; Gurevich VV; Benovic JL; Gurevich EV
Neurobiol Dis; 2005 Mar; 18(2):323-35. PubMed ID: 15686961
[TBL] [Abstract][Full Text] [Related]
4. GRKs as Modulators of Neurotransmitter Receptors.
Gurevich EV; Gurevich VV
Cells; 2020 Dec; 10(1):. PubMed ID: 33396400
[TBL] [Abstract][Full Text] [Related]
5. G Protein-Coupled Receptor Kinase 2 Selectively Enhances β-Arrestin Recruitment to the D
Sánchez-Soto M; Boldizsar NM; Schardien KA; Madaras NS; Willette BKA; Inbody LR; Dasaro C; Moritz AE; Drube J; Haider RS; Free RB; Hoffman C; Sibley DR
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892234
[TBL] [Abstract][Full Text] [Related]
6. G protein-coupled receptor kinase-mediated phosphorylation regulates post-endocytic trafficking of the D2 dopamine receptor.
Namkung Y; Dipace C; Javitch JA; Sibley DR
J Biol Chem; 2009 May; 284(22):15038-51. PubMed ID: 19332542
[TBL] [Abstract][Full Text] [Related]
7. Selective recruitment of G protein-coupled receptor kinases (GRKs) controls signaling of the insulin-like growth factor 1 receptor.
Zheng H; Worrall C; Shen H; Issad T; Seregard S; Girnita A; Girnita L
Proc Natl Acad Sci U S A; 2012 May; 109(18):7055-60. PubMed ID: 22509025
[TBL] [Abstract][Full Text] [Related]
8. Multiple functions of G protein-coupled receptor kinases.
Watari K; Nakaya M; Kurose H
J Mol Signal; 2014 Mar; 9(1):1. PubMed ID: 24597858
[TBL] [Abstract][Full Text] [Related]
9. Chapter Three - Ubiquitination and Protein Turnover of G-Protein-Coupled Receptor Kinases in GPCR Signaling and Cellular Regulation.
Penela P
Prog Mol Biol Transl Sci; 2016; 141():85-140. PubMed ID: 27378756
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of GRK6 rescues L-DOPA-induced signaling abnormalities in the dopamine-depleted striatum of hemiparkinsonian rats.
Ahmed MR; Bychkov E; Kook S; Zurkovsky L; Dalby KN; Gurevich EV
Exp Neurol; 2015 Apr; 266():42-54. PubMed ID: 25687550
[TBL] [Abstract][Full Text] [Related]
11. Selective regulation of recombinantly expressed mGlu7 metabotropic glutamate receptors by G protein-coupled receptor kinases and arrestins.
Iacovelli L; Felicioni M; Nisticò R; Nicoletti F; De Blasi A
Neuropharmacology; 2014 Feb; 77():303-12. PubMed ID: 24148810
[TBL] [Abstract][Full Text] [Related]
12. G protein-coupled receptor kinases (GRKs) orchestrate biased agonism at the β
Choi M; Staus DP; Wingler LM; Ahn S; Pani B; Capel WD; Lefkowitz RJ
Sci Signal; 2018 Aug; 11(544):. PubMed ID: 30131371
[TBL] [Abstract][Full Text] [Related]
13. GPCR kinase knockout cells reveal the impact of individual GRKs on arrestin binding and GPCR regulation.
Drube J; Haider RS; Matthees ESF; Reichel M; Zeiner J; Fritzwanker S; Ziegler C; Barz S; Klement L; Filor J; Weitzel V; Kliewer A; Miess-Tanneberg E; Kostenis E; Schulz S; Hoffmann C
Nat Commun; 2022 Jan; 13(1):540. PubMed ID: 35087057
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment with l-DOPA and an mGlu5 receptor antagonist prevents changes in brain basal ganglia dopamine receptors, their associated signaling proteins and neuropeptides in parkinsonian monkeys.
Morin N; Jourdain VA; Morissette M; Grégoire L; Di Paolo T
Neuropharmacology; 2014 Apr; 79():688-706. PubMed ID: 24456747
[TBL] [Abstract][Full Text] [Related]
15. GRK3 suppresses L-DOPA-induced dyskinesia in the rat model of Parkinson's disease via its RGS homology domain.
Ahmed MR; Bychkov E; Li L; Gurevich VV; Gurevich EV
Sci Rep; 2015 Jun; 5():10920. PubMed ID: 26043205
[TBL] [Abstract][Full Text] [Related]
16. Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson's disease.
Lindgren HS; Ohlin KE; Cenci MA
Neuropsychopharmacology; 2009 Nov; 34(12):2477-88. PubMed ID: 19606087
[TBL] [Abstract][Full Text] [Related]
17. Suitability of GRK Antibodies for Individual Detection and Quantification of GRK Isoforms in Western Blots.
Reichel M; Weitzel V; Klement L; Hoffmann C; Drube J
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163118
[TBL] [Abstract][Full Text] [Related]
18. Delineation of G Protein-Coupled Receptor Kinase Phosphorylation Sites within the D
Moritz AE; Madaras NS; Rankin ML; Inbody LR; Sibley DR
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047571
[TBL] [Abstract][Full Text] [Related]
19. G protein-coupled receptor kinases: more than just kinases and not only for GPCRs.
Gurevich EV; Tesmer JJ; Mushegian A; Gurevich VV
Pharmacol Ther; 2012 Jan; 133(1):40-69. PubMed ID: 21903131
[TBL] [Abstract][Full Text] [Related]
20. Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia.
Farré D; Muñoz A; Moreno E; Reyes-Resina I; Canet-Pons J; Dopeso-Reyes IG; Rico AJ; Lluís C; Mallol J; Navarro G; Canela EI; Cortés A; Labandeira-García JL; Casadó V; Lanciego JL; Franco R
Mol Neurobiol; 2015 Dec; 52(3):1408-1420. PubMed ID: 25344317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
